Current status and future directions of disease modifying therapy in multiple sclerosis

被引：0

作者：

Segal, Benjamin M. ^{[1
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

212-MEDI

引用

收藏

页数：1

相关论文

共 50 条

[41] CURRENT STATUS AND FUTURE-DIRECTIONS OF ANTIFUNGAL THERAPY
STEVENS, DA
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1994, 3 : S97 - S102
[42] Electron Beam Therapy - Current Status and Future Directions
Wu, Q.
MEDICAL PHYSICS, 2015, 42 (06) : 3662 - 3662
[43] A review of proton therapy - Current status and future directions
Mohan, Radhe
PRECISION RADIATION ONCOLOGY, 2022, 6 (02): : 164 - 176
[44] Disease modifying therapy in the aging multiple sclerosis patient
Corboy, J. R.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 83 - 83
[45] Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis
Longbrake, Erin E.
Parks, Becky J.
Cross, Anne H.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (11)
[46] Multiple sclerosis disease-modifying therapy and pregnancy
Miller, Aaron E.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
[47] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
Tanuja Chitnis
Neurotherapeutics, 2013, 10 : 89 - 96
[48] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
Chitnis, Tanuja
NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
[49] Stopping Disease Modifying Therapy in Multiple Sclerosis Patients
Presas, Silvia
Vicente Hervas-Garcia, Jose
Ramo-Tello, Cristina
NEUROLOGY, 2016, 86
[50] Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis
Erin E. Longbrake
Becky J. Parks
Anne H. Cross
Current Neurology and Neuroscience Reports, 2013, 13

← 1 2 3 4 5 →